(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 5.55% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.72%.
Airsculpt Technologies's revenue in 2026 is $151,818,000.On average, 4 Wall Street analysts forecast AIRS's revenue for 2026 to be $11,142,690,314, with the lowest AIRS revenue forecast at $10,612,186,793, and the highest AIRS revenue forecast at $11,570,197,141. On average, 4 Wall Street analysts forecast AIRS's revenue for 2027 to be $11,865,783,544, with the lowest AIRS revenue forecast at $10,840,049,342, and the highest AIRS revenue forecast at $12,814,622,954.
In 2028, AIRS is forecast to generate $12,786,404,681 in revenue, with the lowest revenue forecast at $11,345,156,418 and the highest revenue forecast at $14,170,510,942.